BRCA1 and neoplasm: In fact, we could hypothesize that, given that BRCA1/2-mutated high grade serous ovarian cancers (HGSOCs) exhibit a higher mutational load and a unique mutational signature, with an elevated number of larger indels up to 50 bp, these tumors may also harbor more tumor-specific neoantigens [13].